Targeting CD47 Inhibits Tumor Development and Increases Phagocytosis in Oral Squamous Cell Carcinoma

Anticancer Agents Med Chem. 2021;21(6):766-774. doi: 10.2174/1871520620999200730162915.

Abstract

Background: Our previous work demonstrated upregulated CD47 in Oral Squamous Cell Carcinoma (OSCC).

Objective: In the present study, we aimed to investigate the effects of CD47 on tumor cell development and phagocytosis in OSCC and elucidate the underlying mechanisms.

Methods: The proliferation, apoptosis, migration, and invasion of oral cancer cells were analyzed after knocking down the expression of CD47. The effects of CD47 on tumor development were also evaluated using a murine model of OSCC. The involvement of CD47 in the phagocytosis of oral cancer cells was identified.

Results: Cell proliferation was suppressed by knocking down the expression of CD47 in human OSCC cell line Cal-27 cells but there was no change in the apoptosis rate. Moreover, impaired expression of CD47 inhibited the migration and invasion of Cal-27 cells. Furthermore, we found that nude mice injected with CD47 knockeddown Cal-27 cells displayed decreased tumor volumes at week 9 compared to xenograft transplantations of blank Cal-27 cells. In addition, in vitro phagocytosis of Cal-27 cells by macrophages was significantly enhanced after the knockdown of CD47, which positively correlated with compromised STAT3/JAK2 signaling.

Conclusion: In summary, the knockdown of CD47 downregulated the development of OSCC and increased the phagocytosis of Cal-27 cells, indicating that CD47 might be a promising therapeutic target.

Keywords: CD47; Cell proliferation; STAT3/JAK2 signaling; macrophage; tumor development; xenograft transplantations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis
  • CD47 Antigen / genetics
  • CD47 Antigen / metabolism*
  • Cell Line, Tumor
  • Cell Proliferation
  • Gene Expression Regulation, Neoplastic
  • Gene Knockdown Techniques
  • Head and Neck Neoplasms / metabolism*
  • Head and Neck Neoplasms / therapy
  • Humans
  • Janus Kinase 2 / metabolism
  • Macrophages / metabolism
  • Mice
  • Mice, Nude
  • Phagocytosis / genetics*
  • STAT3 Transcription Factor / metabolism
  • Signal Transduction
  • Squamous Cell Carcinoma of Head and Neck / metabolism*
  • Squamous Cell Carcinoma of Head and Neck / therapy
  • Xenograft Model Antitumor Assays

Substances

  • CD47 Antigen
  • STAT3 Transcription Factor
  • Janus Kinase 2